Decision to list needles and syringes products supplied by Becton Dickinson Limited and Terumo Australia Pty Limited
3 May 2019
What we are doing
We are pleased to announce the approval of two non-exclusive listing agreements (“Agreements”) with Becton Dickinson Limited (“BD“) and Terumo Australia Pty Limited (“Terumo”) for the supply of needle and syringe products to DHBs.
In summary this will result in:
- BD’s needle and syringe products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 June 2019; and
- Terumo’s needle and syringe products being listed in Part III of Section H of the Pharmaceutical Schedule from 1 June 2019
As these are non-exclusive listing agreements, DHBs will continue to be able to purchase other suppliers’ brands of needle and syringe products.
These are the final Pharmaceutical Schedule listing agreements to eventuate from the 2017 Needles and Syringes Requests for Proposals (“RFP”).
Any changes to the original proposals?
This decision was subject to the following consultation letters:
There were no changes to the agreements following consultation.
Who we think will be most interested
- Suppliers and wholesalers
- All DHB clinical staff including but not limited to:
- Allied Health staff;
- Clinical Engineers;
- Clinical and technical staff working in surgical and medical units, emergency departments, intensive and critical care units, and perioperative and outpatient units
- District nurses
- Procurement Officers and supply chain personnel.
Detail about this decision
The RFP was for non-exclusive national agreements for listing in the Pharmaceutical Schedule.
After completing the RFP evaluation processes and consulting on the individual provisional Agreements reached with BD and Terumo PHARMAC has decided to list both BD’s and Terumo’s ranges of needles and syringes in Part III of Section H of the Pharmaceutical Schedule.
DHBs that purchase BD’s and/or Terumo’s needles and syringes must do so under the terms and conditions and at the prices included in the Agreements, from 1 June 2019. DHBs can continue to choose which needles and syringes they purchase.
No further agreements with suppliers of needles and syringes will eventuate from the 2017 needles and syringes RFP.
Our response to what you told us
We’re really grateful for the time people took to respond to this consultation.
A summary of the main theme raised in feedback and our responses to the feedback received, are set out below.
PHARMAC Staff Comment
Becton Dickinson and Terumo Agreements
Ministry of Health
Advising no technical resource impacts anticipated as a result of proposal.
Noted that the pack sizes for some products included were not suitable.
Noted. DHBs can continue to purchase alternative products which better suit their individual needs. DHBs are not required to purchase products included in this agreement.
If you have any questions about this decision, you can email us at firstname.lastname@example.org; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.
Last updated: 16 July 2020